The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Syrkin A.L.

Sechenov First Moscow State Medical University

Salagaev G.I.

Chair of Cardiovascular Surgery and Interventional Cardiology, I.M. Sechenov First Moscow State Medical University (head — MD R.N. Komarov), acad. B.V. Petrovsky Russian Research Center for Surgery (director — acad. of RAS Yu.V. Belov), Moscow, Russia

Syrkina E.A.

Chair of Preventive and Emergency Cardiology, Research Center of Mental Health RAS, Moscow, Russia

Lysenko A.V.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Advantages of magnesium orotate for correction of magnesium deficiency in patients with various heart rhythm disturbances (in Russian only)

Authors:

Syrkin A.L., Salagaev G.I., Syrkina E.A., Lysenko A.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2019;12(4): 308‑313

DOI: 10.17116/kardio201912041308

Views: 104620

Downloaded: 946

Download PDF (RU)
Download PDF
Contact the author
Table of contents

ADVANTAGES OF MAGNESIUM OROTATE FOR CORRECTION OF MAGNESIUM DEFICIENCY IN PATIENTS WITH VARIOUS HEART RHYTHM DISTURBANCES (IN RUSSIAN ONLY)
ADVANTAGES OF MAGNESIUM OROTATE FOR CORRECTION OF MAGNESIUM DEFICIENCY IN PATIENTS WITH VARIOUS HEART RHYTHM DISTURBANCES (IN RUSSIAN ONLY)

To cite this article:

Syrkin AL, Salagaev GI, Syrkina EA, Lysenko AV. Advantages of magnesium orotate for correction of magnesium deficiency in patients with various heart rhythm disturbances (in Russian only). Russian Journal of Cardiology and Cardiovascular Surgery. 2019;12(4):308‑313. (In Russ., In Engl.)
https://doi.org/10.17116/kardio201912041308

Подписка 2025-2 (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Cryoballoon abla­tion for pulmonary vein isolation in the treatment of chro­nic heart failure with redu­ced left ventricular ejection fraction following tachycardia-induced cardiomyopathy. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(2):222-227
In-hospital resu­lts of thoracoscopic box-lesion radiofrequency left atrial abla­tion for atrial fibrillation. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):483-488
A modi­fied method of left atrial radiofrequency abla­tion for atrial fibrillation in a patient unde­rgoing mitral valve replacement under warm blood cardioplegia. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):556-560
Venous Thro­mboembolism in Women with Chro­nic Venous Disease of the Lower Extremities Receiving Direct Oral Anti­coagulants for Atrial Fibrillation. Journal of Venous Diso­rders. 2024;(2):106-114
Venous Thro­mboembolism in Women with Chro­nic Venous Disease of the Lower Extremities Receiving Direct Oral Anti­coagulants for Atrial Fibrillation. Journal of Venous Diso­rders. 2024;(2):106-114
Evaluation of clinical effi­cacy and effi­ciency of new anti­coagulants and sodium-glucose cotransporter 2 inhi­bitors in patients with coro­nary artery disease and concomitant cardiovascular diseases. Medi­cal Technologies. Asse­ssment and Choice. 2024;(3):115-123
Atrial fibrillation and bleeding as complications of targeted therapy in chro­nic lymphocytic leukemia with impact on cardiovascular mortality. Russian Cardiology Bulletin. 2024;(3):16-25
The role of imba­lance of myocardial cell adhe­sion proteins in cardiac arrhythmia and heart failure. Russian Journal of Archive of Pathology. 2024;(5):75-80
Predictors of atrial fibrillation recu­rrence after biatrial cryo-maze procedure: a systematic review. Piro­gov Russian Journal of Surgery. 2024;(11):100-104
Imme­diate outcomes of simu­ltaneous Cox-Maze procedure in patients with isolated and multivalvular heart defe­cts via right mini-thoracotomy. Piro­gov Russian Journal of Surgery. 2024;(12-2):18-24

Abstract Prevalence of magnesium deficiency, its role in rhythm disturbances, risks associated with magnesium deficiency and advisability of magnesium orotate intake for heart rhythm disturbances are reviewed in the article. Metaanalyzes data on clinical effectiveness of magnesium orotate for arrhythmias and other manifestations of hypomagnesemia are presented. Metabolic feasibility of orotic magnesium salt due to cardioprotective effect is shown. Case report of effective correction of electrolyte disturbances with the Magnerot in a patient with hypomagnesemia is given.

Keywords:

heart rhythm disturbances
magnesium
atrial fibrillation
extrasystole
Magnerot
magnesium orotate

Authors:

Syrkin A.L.

Sechenov First Moscow State Medical University

Salagaev G.I.

Chair of Cardiovascular Surgery and Interventional Cardiology, I.M. Sechenov First Moscow State Medical University (head — MD R.N. Komarov), acad. B.V. Petrovsky Russian Research Center for Surgery (director — acad. of RAS Yu.V. Belov), Moscow, Russia

Syrkina E.A.

Chair of Preventive and Emergency Cardiology, Research Center of Mental Health RAS, Moscow, Russia

Lysenko A.V.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

List of references:

  1. National Institutes of Health, Magnesium, National Institutes of Health, Bethesda, Maryland, USA, 2018. https:// ods.od.nih.gov/factsheets/Mg2+-HealthProfessional/
  2. Qu X, Jin F, Hao Y, et al. Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLoS One. 2013;8(3): Article ID e57720.
  3. Iseri LT, Allen BJ, Ginkel ML, Brodsky MA. Ionic biology and ionic medicine in cardiac arrhythmias with particular reference to magnesium. American Heart Journal. 1992;123(5):1404-1409.
  4. Mubagwa K, Gwanyanya A, Zakharov S, Macianskiene R. Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium. Archives of Biochemistry and Biophysics. 2007;458(1):73-89.
  5. Rasmussen HS, Thomsen PEB. The electrophysiological effects of intravenous magnesium on human sinus node, atrioventricular node, atrium, and ventricle. Clinical Cardiology. 1989;12(2):85-90.
  6. Stiles MK, Sanders P, Disney P, et al. Differential effects of intravenous magnesium on atrioventricular node conduction in supraventricular tachycardia. American Journal of Cardiology. 2007;100(8):1249-1253.
  7. Satoh Y, Sugiyama A, Tamura K, Hashimoto K. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential. Japanese Circulation Journal. 2000;64(6):445-451.
  8. Wu J, Eand S, Lipsius L. Effects of extracellular Mg2+ on T and L-type Ca2+ currents in single atrial myocytes. American Journal of Physiology-Heart and Circulatory Physiology. 1990;259(6):H1842-H1850.
  9. Sheehan J P, Seelig MS. Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease. Magnesium. 1984;3(4-6):301-314.
  10. Leor J, Kloner RA. An experimental model examining the role of magnesium in the therapy of acute myocardial infarction. American Journal of Cardiology. 1995;75(17):1292-1293.
  11. Paravicini TM, ChubanovV, Gudermann T. TRPM7: a unique channel involved in magnesium homeostasis. International Journal of Biochemistry & Cell Biology. 2012;44(8):1381-1384.
  12. Weiner ID, Wingo CS. Hypokalemia: Consequences, causes, and correction. J Am Soc Nephrol. 1997;8:1179-1188.
  13. Solomon R. The relationship between disorders of K+ and Mg2+ homeostasis. Semin Nephrol. 1987;7:253-262.
  14. Whang R, Welt LA. Observations in experimental magnesium depletion. J Clin Invest. 1963;42:305-313.
  15. Wong NLM, Sutton RA, Navichak V, Quame GA, Dirks JH: Enhanced distal absorption of potassium by magnesium-deficientrats. Clin Sci. 1985;69:626-639.
  16. Baehler RW, Work J, Kotchen TA, McMorrow G, Guthrie G: Studies on the pathogenesis of Bartter’s syndrome. Am J Med. 1980;69:933-938.
  17. Shechter M. Magnesium and cardiovascular system. Magnes Res. 2010;23:60-72.
  18. AHA (ECC Guidelines). Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 8: Advanced challenges in resuscitation: Section 1: Life-threatening electrolyte abnormalities. Circulation. 2000;102:I217-1222.
  19. Del Gobbo LC, Imamura F, Wu JHY, de Oliveira Otto MC, Chiuve SE, Mozaffarian D. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and metaanalysis of prospective studies. Am J Clin Nutr. 2013;98:160-173.
  20. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med. 2006;23:1050-1056.
  21. Ohira T, Peacock JM, Iso H, Chambless LE, Rosamond WD, Folsom AR. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2009;169:1437-1444.
  22. Amighi J, Sabeti S, Schlager O, Mlekusch W, Exner M, Lalouschek W, Ahmadi R, Minar E, Schillinger M. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke. 2004;35:22-27.
  23. Salaminia S, Sayehmiri F, Angha P, Sayehmiri K, Motedayen M. Evaluating the effect of magnesium supplementation and cardiac arrhythmias after acute coronary syndrome: a systematic review and metaanalysis. BMC Cardiovascular Disorders. 2018;18(1):129.
  24. Horner SH. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Metaanalysis of magnesium in acute myocardial infarction. Circulation. 1992;86(3):774-779.
  25. Shiga T, Wajima ZI, Inoue T, Ogawa R. Magnesium prophylaxis for arrhythmias after cardiac surgery: a metaanalysis of randomized controlled trials. American Journal of Medicine. 2004;117(5):325-333.
  26. Alghamdi AA, Al-Radi OO, Latter DA. Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and metaanalysis. Journal of Cardiac Surgery. 2005;20(3):293-299.
  27. Khan AM, Lubitz SA, Sullivan LM, et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham heart study. Circulation. 2013;127(1):33-38.
  28. Raghu C, Peddeswara RR, Seshagiri Rao D. Protective effect of intravenous magnesium in acute myocardial infarction following thrombolytic therapy. International Journal of Cardiology. 1999;71(3):209-215.
  29. Zaman AG, Alamgir F, Richens T, Williams R, Rothman MT, Mills PG. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery. Heart. 1997;77:527-531. PubMed: 9227296
  30. Lasebnik LB, Drozdova SL. Korrectsiya magnievogo defitsita pri serdechno-sosudistoy patologii. Kardiologiya. 1997;(5):103-104. (In Russ.)
  31. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace. 2015;17(11):1601-1687.
  32. Hoshino K, Ogawa K, Hishitani T, et al. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome. Pediatr Int. 2006;48(2):112-117.
  33. Ragozina NP, Churin KV, Churna SK. Peroral’nye preparaty magnita pri ostrom infarkte miokarda: vliyanie na techenie zabolevaniya i razvitie aritmiy. Vestnik aritmologii. 2000;19:23-28. (In Russ.)
  34. Zehender M, Meinertz T, Just H. Magnesium deficiency and magnesium substitution. Effect on ventricular cardiac arrhythmias of various etiology. Herz. 1997;22(1):56-62.
  35. Ezhov AV, Pimenov LT, Zamost’yanov MV. Klinicheskaya ffectivnost’ Magnerota v lechenii stabilnoy stenokardii napryazheniya v sochetanii s arterialnoy gipetensiey u lits pozhilogogo vozrasta. Rossiyskie meditsinskie vesti. 2001;1:71-74. (In Russ.)
  36. Haase C. Einfluß von Magnesiumorotat auf den antiarrhythmischen Therapiebedarf bei supraventrikulären Arrhythmien nach aortokoronarer Bypassoperation (interne Dokumentation). Wörwag Pharma, 1995.
  37. Torshilin IYu, Gromova OA, Fedotova LE, et al. Chemoinformatsionny analiz molekuly orotovoy kisloty ukazyvaet na protivovospalitelnye, neyroprotektivnye i kardiopotektivnye svoistva liganda magniya. Farmateka. 2013;13:95-103. (In Russ.)
  38. Jellinek H, Takacs E. Morphological aspects of the effects of orotic acid and magnesium. Arzneimittelforschung. 1995;45(8):836-842.
  39. Williams JF, et al. Biochemistry and functional roles of orotic acid for support of the infarcted heart during open heart surgery. In: Williams JF. Orotic acid in cardiology. Stuttgart—New York: Georg Thieme Verlag, 1992;1-24.
  40. Sueta C, Clarke S, Dunlap S. Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation. 1994;89:660-666.
  41. Iezhitsa I. Potassium and magnesium depletions in congestive heart ailurepathophysiology, consequences and replenishment. Clin Calcium. 2005;15(11):123-133.
  42. Etienne Y, Blanc J, Boschat J, et al. Anti-arrhythmic effects of intravenous magnesium sulfate in paroxysmal supraventricular tachycardia. Am Cardiol Angeiol. 1988;37(9):535-538.
  43. Camm A, Janse M, Roden D, et al. Congenital and acquired long QT syndrome. Eur Heart J. 2000;21(15):1232-1237.
  44. Torshin IYu, Gromova OA, Kalacheva AG, Oshchepkova EV, Martunov AI. Metaanaliz klinicheskikh issledovaniy vozdeystviya orotata magniya na serdechno-sosudituyu sistemu. Ter arhiv. 2015;6:88-97. (In Russ.) https://doi.org/10.17116/terarkh201587688-97
  45. Ryzen E, Wagers PW, Singer FR, Rude RK. Magnesium deficiency in a medical ICU population. Crit Care Med. 1985;13:19-21.
  46. Teo KK, Yusuf S, Collins R, et al. Effects of intravenous magnesium in suspected acute myocardial infarction. Overview of randomized trials. Brit Med J. 1991;303:1499-1503.
  47. Chiuve SE, Korngold EC, Januzzi JL, et al. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. 2011;93(2):253-260.
  48. Moisa C, Vicas LG, Ganea M, Levei EA, Cadar O, Berce C. Murine studies regarding the tissue intake of different magnesium compounds. Farmacia. 2018;66(1):176-180.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.